Quarterly report pursuant to Section 13 or 15(d)

Stock Incentive Plan

v3.22.1
Stock Incentive Plan
3 Months Ended
Mar. 31, 2022
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock Incentive Plan
NOTE 15. STOCK INCENTIVE PLAN
Our Amended and Restated 1999 Stock Incentive Plan (the “Plan”) provides for grants of equity-based awards to employees,
non-employee
directors and officers, and advisors (“Eligible Persons”). A maximum of 8,000,000 shares are authorized under the Plan of which 2,450,811 were available for issuance at March 31, 2022. Insiders may participate in plans established pursuant to Rule
10b5-1
under the Exchange Act that allow them to exercise awards subject to
pre-established
criteria.
We recognize
non-cash
stock-based compensation expense based on the estimated fair value of awards in accordance with FASB ASC Topic 718 “
Compensation—Stock Compensation
.” Stock-based compensation expense fluctuates over time as a result of the vesting periods for outstanding awards and the number of awards that actually vest.
The following table reflects the components of stock-based compensation expense recognized in the Condensed Consolidated Statements of Operations for the three-month periods ended March 31, 2022 and 2021:
                 
    
Three Months Ended
March 31,
 
    
2021
    
2022
 
    
(Dollars in thousands)
 
Stock option compensation expense included in corporate expenses
   $ 28     
$
2
 
Restricted stock shares compensation expense included in corporate expenses
     —       
 
54
 
Stock option compensation expense included in broadcast operating expenses
     28     
 
30
 
Stock option compensation expense included in digital media operating expenses
     22     
 
20
 
    
 
 
    
 
 
 
Total stock-based compensation expense,
pre-tax
   $ 78     
$
106
 
    
 
 
    
 
 
 
Tax provision for stock-based compensation expense
     (20   
 
(28
    
 
 
    
 
 
 
Total stock-based compensation expense, net of tax
   $ 58     
$
78
 
    
 
 
    
 
 
 
Stock Option and Restricted Stock Grants
Eligible employees may receive stock option awards annually with the number of shares and type of instrument generally determined by the employee’s salary grade and performance level. Incentive and
non-qualified
stock option awards allow the recipient to purchase shares of our common stock at a set price, not to be less than the closing market price on the date of award, for no consideration payable by the recipient. The related number of shares underlying the stock option is fixed at the time of the grant. Options generally vest over a four-year period with a maximum term of five years from the vesting date. In addition, certain management and professional level employees may receive stock option awards upon the commencement of employment.
The Plan also allows for awards of restricted stock that contain transfer restrictions under which they cannot be sold, pledged, transferred, or assigned until the period specified in the award, generally from
one to five years. Restricted stock awards are independent of option grants and are granted at no cost to the recipient other than applicable taxes owed by the recipient. The awards are considered issued and outstanding from the date of grant.
The fair value of each award is estimated as of the date of the grant using the Black-Scholes valuation model. The expected volatility reflects the consideration of the historical volatility of our common stock as determined by the closing price over a six to
ten-year
term commensurate with the expected term of the award. Expected dividends reflect the amount of quarterly distributions authorized and declared on our Class A and Class B common stock as of the grant date. The expected term of the awards is based on evaluations of historical and expected future employee exercise behavior. The risk-free interest rates for periods within the expected term of the award are based on the U.S. Treasury yield curve in effect during the period the options were granted. We have used historical data to estimate future forfeiture rates to apply against the gross amount of compensation expense determined using the valuation model. These estimates have approximated our actual forfeiture rates.
The weighted-average assumptions used to estimate the fair value of the stock options using the Black-Scholes valuation model were as follows for the three-month periods ended March 31, 2022 and 2021:
                 
    
Three Months Ended
March 31, 2021
   
Three Months Ended
March 31, 2022
 
Expected volatility
     74.83     84.69
Expected dividends
     0.00     0.00
Expected term (in years)
     7.7       9.5  
Risk-free interest rate
     0.96     1.61
Activity with respect to the company’s option awards during the three-month period ended March 31, 2022 is as follows:
                                         
Options
   Shares     Weighted
Average
Exercise Price
     Weighted
Average Grant
Date
Fair Value
     Weighted Average
Remaining
Contractual Term
     Aggregate
Intrinsic
Value
 
    
(Dollars in thousands, except weighted average exercise price and weighted
average grant date fair value)
 
Outstanding at January 1, 2022
     1,900,417     $ 3.01      $ 1.37        4.4 years      $ 1,310  
Granted
     100,000       3.26        2.66                 —    
Exercised
     (40,913     2.31        1.16                 50  
Forfeited or expired
     (161,664     6.09        3.48                 —    
    
 
 
                                    
Outstanding at March 31, 2022
  
 
1,797,840
 
 
 
2.76
 
  
 
1.25
 
  
 
4.8 years
 
  
$
1,640
 
    
 
 
                                    
Exercisable at March 31, 2022
  
 
963,590
 
 
 
3.38
 
  
 
1.38
 
  
 
3.1 years
 
  
 
523
 
    
 
 
                                    
Expected to Vest
  
 
792,120
 
 
 
2.78
 
  
 
1.26
 
  
 
4.7 years
 
  
$
1,584
 
    
 
 
                                    
On March 1, 2022, we issued 8,170
restricted shares that vested immediately to our Chief Operating Officer under an election made pursuant to his employment agreement. The fair value of the restricted stock award was measured based on the grant date market price of our common shares. The restricted stock award contains transfer restrictions under which they cannot be sold, pledged, transferred, or assigned for two years. The restricted stock awards provide all the rights of absolute ownership of the restricted stock from the date of grant, including the right to vote the shares and to receive dividends. Restricted stock awards are independent of option grants and are granted at no cost to the recipient other than applicable taxes owed by the recipient. The awards are considered issued and outstanding from the date of grant.
On March 2, 2022, we issued 6,684
restricted shares that vested immediately to our Chief Executive Officer under an election made pursuant to his employment agreement. The fair value of the restricted stock award was measured based on the grant date market price of our common shares. The restricted stock award contains transfer restrictions under which they cannot be sold, pledged, transferred, or assigned for two years. The restricted stock awards provide all the rights of absolute ownership of the restricted stock from the date of grant, including the right to vote the shares and to receive dividends. Restricted stock awards are independent of option grants and are granted at no cost to the recipient other than applicable taxes owed by the recipient. The awards are considered issued and outstanding from the date of grant.
Activity with respect to the company’s restricted stock awards during the three-month period ended March 31, 2022 is as follows:
                                 
Restricted Stock Awards
   Shares      Weighted Average
Grant Date Fair Value
     Weighted Average
Remaining Contractual Term
     Aggregate
Intrinsic Value
 
    
(Dollars in thousands, except weighted average exercise price and weighted average
grant date fair value)
 
Outstanding at January 1, 2022
     —          —          —          —    
Granted
     14,854        3.66        —       
$
54
 
Lapsed
     —       
 
—  
 
     —          —    
Forfeited
     —       
 
—  
 
     —          —    
    
 
 
                            
Outstanding at March 31, 2022
  
 
14,854
 
  
 
3.66
 
  
 
1.9
 
  
$
50
 
    
 
 
                            
The aggregate intrinsic value represents the difference between the company’s closing stock price on March 31, 2022 of $3.39 and the option exercise price of the shares for stock options that were in the money, multiplied by the number of shares underlying such options. The total fair value of options vested during the periods ended March 31, 2022 and 2021
,
was $0.2 million and $0.1 million, respectively.
As of March 31, 2022, there was $0.1 million of total unrecognized compensation cost related to
non-vested
stock option awards. This cost is expected to be recognized over a weighted-average period of 3.2 years.